Medical 21

Medical 21 has been recognized as an Innovation Leader at LSI's Q3 2017 Virtual Emerging Medtech Spotlight.

Manny

Dr. Manny Villafaña

Chief Executive Officer

Medical 21 Artificial blood vessels using cellulose and an external support made of nitinol as an alternative to harvesting blood vessels for coronary artery bypass graft surgeries
Share

Upcoming LSI Events

Trusted By The Companies Pioneering What’s Next

  • 0-Minnetronix.png
  • 1-jnj.png
  • 2-medtronic.png
  • 3-abbott.png
  • 4-baxter.png
  • 5-mckinsey.png
  • 7-bostonscientific.png
  • 8-bd.png
  • 9-smithnephew.png
  • 10-stryker.png
  • 33m.png
  • allergan.png
  • bbraun.png
  • beckmancoulter.png
  • cardinal.png
  • depuysynthes.png
  • drager.png
  • edwardslifesciences.png
  • ethicon.png
  • ge.png
  • gore.png
  • health-advances.png
  • hospira.png
  • jlabs.png
  • kimberlyclark.png
  • merck.png
  • olympus.png
  • orthofix.png
  • philips.png
  • sanofigenzyme.png
  • tecan.png
  • teleflex.png
  • terumo.png
  • zimmerbiomet.png